Martin Forrest Healthcare News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected healthcare news for Martin Forrest, which is filed under People. There are 29 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
7/29/2020 Five Prime Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference | Business & Finance | heraldchronicle.com
... in clinical and preclinical development. For more information, please visit https://www.fiveprime.com . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200729006073/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA ...
Business Wire
7/29/2020 Five Prime Therapeutics Announces Timing of Its Second Quarter 2020 Results Conference Call | Business & Finance | heraldchronicle.com
... in clinical and preclinical development. For more information, please visit https://www.fiveprime.com . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200729006049/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA ...
Business Wire
4/22/2020 Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format | Business & Finance | heraldchronicle.com
... information, please visit www.fiveprime.com or follow us on LinkedIn , Twitter and Facebook . Source: Five Prime Therapeutics, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20200422005924/en/ CONTACT: Media and Investor Contact Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA ...
Business Wire
3/13/2020 Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology | Business & Finance | heraldchronicle.com Business Wire
12/30/2019 Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference Business Wire
12/30/2019 Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference | Business & Finance | manchestertimes.com Business Wire
11/9/2019 Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting Business Wire
11/9/2019 Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting Business Wire
10/10/2019 Five Prime Announces Restructuring | Business & Finance | manchestertimes.com Business Wire
9/30/2019 Five Prime Therapeutics Presents Updated Data From the Phase 1a/1b Trial of FPA150 at the European Society for Medical Oncology 2019 Congress Business Wire
9/30/2019 Five Prime Therapeutics Presents Updated Data From the Phase 1a/1b Trial of FPA150 at the European Society for Medical Oncology 2019 Congress | Business & Finance | heraldchronicle.com Business Wire
8/23/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference Business Wire
8/22/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference | Business & Finance | heraldchronicle.com Business Wire
8/10/2019 Five Prime Therapeutics, Inc. (FPRX) Aron Knickerbocker Seeking Alpha
8/1/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference Business Wire
8/1/2019 Five Prime Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call Business Wire
8/1/2019 Five Prime Therapeutics to Present at Upcoming Healthcare Conference Business Wire
8/1/2019 Five Prime Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call Business Wire
5/10/2019 Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q1 2019 Results - Earnings Call Transcript Seeking Alpha
5/9/2019 Five Prime Therapeutics (FPRX) Q1 2019 Earnings Call Transcript Yahoo News